EcoDrugPlus

Glucokinase (Hexokinase 4)

Ensembl ID : ENSEBUG00000003343
Gene Symbol: GCK
1 Cross references
216 Possible Orthologues:

Glucosylceramidase Beta 1

Ensembl ID : ENSEBUG00000006665
Gene Symbol: GBA1
1 Cross references
256 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSEBUG00000012124
Gene Symbol: GRIK5
1 Cross references
304 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSEBUG00000012800
Gene Symbol: GRM2
1 Cross references
280 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSEBUG00000012562
Gene Symbol: GRIN1A
1 Cross references
281 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSEBUG00000004739
Gene Symbol: GRM5B
1 Cross references
582 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSEBUG00000012948
Gene Symbol: GSK3AA
1 Cross references
504 Possible Orthologues:

Growth Hormone Secretagogue Receptor A

Ensembl ID : ENSEBUG00000015062
Gene Symbol: GHSRA
1 Cross references
286 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSEBUG00000002662
Gene Symbol: GUCY1A2
1 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSEBUG00000003149
Gene Symbol: GUCY1B1
1 Cross references
211 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class A Member 1, Tandem Duplicate 2

Ensembl ID : ENSEBUG00000003019
Gene Symbol: HSP90AA1.2
1 Cross references
389 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSEBUG00000009741
Gene Symbol: HDAC11
1 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).